AKTX vs BDRX
Akari Therapeutics PLC · Biodexa Pharmaceticals
Relative return (rebased to 100)
Key stats
| Metric | AKTX | BDRX |
|---|---|---|
| Price | $7.37 | $2.48 |
| Market Cap | $1.15T | $559.92B |
| P/E | — | — |
| P/B | 61734.66 | 74745.06 |
| P/S | 3120488.47 | — |
| ROE | -93.0% | — |
| Net Margin | -4702.1% | — |
| Gross Margin | — | — |
| Revenue Growth | -39.5% | — |
| Dividend Yield | — | — |
| EPS | -$0.00 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.